Mitomycin C (1) is a clinically significant antineoplastic antibiotic. In this proposal, a novel hypothesis for the mode of action of this drug is presented. Evidence is cited in support of this pathway. Detailed experiments are proposed to substantiate this mechanism as well as to determine the energetics of key steps. Emphasis has been placed on elucidating the mechanism of the drug-receptor (DNA) interaction. Knowledge of which route is the correct reaction pathway in mitomycin C-mediated processes may provide the molecular basis for subsequent research in cancer chemotherapy and allow future general drug design to proceed on a less empirical basis.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research Project (R01)
Project #
2R01CA029756-07A1
Application #
3168853
Study Section
Bio-Organic and Natural Products Chemistry Study Section (BNP)
Project Start
1981-05-01
Project End
1991-03-31
Budget Start
1988-04-01
Budget End
1989-03-31
Support Year
7
Fiscal Year
1988
Total Cost
Indirect Cost
Name
University of Houston
Department
Type
Schools of Arts and Sciences
DUNS #
800771594
City
Houston
State
TX
Country
United States
Zip Code
77204
Lee, Sang Hyup; Kohn, Harold (2009) Nucleophilic activation of a tetra-substituted mitomycin cyclic bis-disulfide. Chem Pharm Bull (Tokyo) 57:149-57
Lee, Sang Hyup; Kohn, Harold (2005) 7-N,7'-N'-(1"",2""-Dithianyl-3"",6""-dimethylenyl)bismitomycin C: synthesis and nucleophilic activation of a dimeric mitomycin. Org Biomol Chem 3:471-82
Lee, Sang Hyup; Kohn, Harold (2004) Cyclic disulfide C8 iminoporfiromycin: nucleophilic activation of a porfiromycin. J Am Chem Soc 126:4281-92
Na, Younghwa; Wang, Shuang; Kohn, Harold (2002) 7-N-(mercaptoalkyl)mitomycins: implications of cyclization for drug function. J Am Chem Soc 124:4666-77
Lee, Sang Hyup; Kohn, Harold (2002) Efficient synthesis of medium-sized cyclic ether diamines. J Org Chem 67:1692-5
Zewail-Foote, M; Li, V S; Kohn, H et al. (2001) The inefficiency of incisions of ecteinascidin 743-DNA adducts by the UvrABC nuclease and the unique structural feature of the DNA adducts can be used to explain the repair-dependent toxicities of this antitumor agent. Chem Biol 8:1033-49
Li, V S; Tang, M S; Kohn, H (2001) The effect of C(5) cytosine methylation at CpG sequences on mitomycin-DNA bonding profiles. Bioorg Med Chem 9:863-73
Na, Y; Li, V S; Nakanishi, Y et al. (2001) Synthesis, DNA cross-linking activity, and cytotoxicity of dimeric mitomycins. J Med Chem 44:3453-62
Li, V S; Reed, M; Zheng, Y et al. (2000) C5 cytosine methylation at CpG sites enhances sequence selectivity of mitomycin C-DNA bonding. Biochemistry 39:2612-8
Wang, S; Kohn, H (1999) Studies on the mode of action of mitomycin C(7) aminoethylene disulfides (BMS-181174 and KW-2149): reactivity of 7-N-(mercaptoethyl)mitomycin C. J Med Chem 42:788-90

Showing the most recent 10 out of 13 publications